BioDuro-Sundia Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
2,000
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
3
BioDuro-Sundia General Information
Description
Operator of a contract research development amd manufacturing organization (CRDMO) intended for commercial drug products. The company offers fully integrated services to support its efforts from target identification to commercial drug product manufacturing, enabling biotech and pharmaceutical partners to deliver their drugs to patients and improve their lives.
Contact Information
Website
www.bioduro.comCorporate Office
- 9601 Jeronimo Road
- Irvine, CA 92618
- United States
Corporate Office
- 9601 Jeronimo Road
- Irvine, CA 92618
- United States
BioDuro-Sundia Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
BioDuro-Sundia Comparisons
Industry
Financing
Details
BioDuro-Sundia Competitors (75)
One of BioDuro-Sundia’s 75 competitors is North American Science Associates, a Private Equity-Backed company based in Toledo, OH.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
North American Science Associates | Private Equity-Backed | Toledo, OH | ||||
NextPharma | Private Equity-Backed | London, United Kingdom | ||||
Axplora | Private Equity-Backed | Raubling, Germany | ||||
Anthem Biosciences | Private Equity-Backed | Bengaluru, India | ||||
CoreRx | Private Equity-Backed | Clearwater, FL |
BioDuro-Sundia Patents
BioDuro-Sundia Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230167132-A1 | Forms and compositions of inhibitors of plasma kallikrein | Pending | 17-Apr-2020 | ||
US-11370803-B2 | Heteroaryl plasma kallikrein inhibitors | Active | 18-Sep-2019 | ||
US-20210078999-A1 | Plasma kallikrein inhibitors and uses thereof | Active | 18-Sep-2019 | ||
US-20210079022-A1 | Heteroaryl plasma kallikrein inhibitors | Active | 18-Sep-2019 | ||
US-20220298176-A1 | Heteroaryl plasma kallikrein inhibitors | Active | 18-Sep-2019 | C07D519/00 |
BioDuro-Sundia Signals
BioDuro-Sundia Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
BioDuro-Sundia Investments (3)
BioDuro-Sundia’s most recent deal was a Buyout/LBO with Sundia MediTech. The deal was made on 24-Sep-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Sundia MediTech | 24-Sep-2020 | Buyout/LBO | BPO/Outsource Services | ||
Molecular Response | 05-Mar-2018 | Buyout/LBO | Biotechnology | ||
Formex | 11-Nov-2015 | Buyout/LBO | Biotechnology |
BioDuro-Sundia Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
Molecular Response | Biotechnology | San Diego, CA |
BioDuro-Sundia FAQs
-
When was BioDuro-Sundia founded?
BioDuro-Sundia was founded in 2005.
-
Where is BioDuro-Sundia headquartered?
BioDuro-Sundia is headquartered in Irvine, CA.
-
What is the size of BioDuro-Sundia?
BioDuro-Sundia has 2,000 total employees.
-
What industry is BioDuro-Sundia in?
BioDuro-Sundia’s primary industry is BPO/Outsource Services.
-
Is BioDuro-Sundia a private or public company?
BioDuro-Sundia is a Private company.
-
What is BioDuro-Sundia’s current revenue?
The current revenue for BioDuro-Sundia is
. -
Who are BioDuro-Sundia’s investors?
Advent International and Bridgewest Group have invested in BioDuro-Sundia.
-
Who are BioDuro-Sundia’s competitors?
North American Science Associates, NextPharma, Axplora, Anthem Biosciences, and CoreRx are some of the 75 competitors of BioDuro-Sundia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »